Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
Authors
Keywords
COVID-19, Vaccination, Cancer patients, Survival, Health care workers
Journal
EUROPEAN JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-02-10
DOI
10.1016/j.ejca.2022.01.035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
- (2021) P. Heudel et al. ESMO Open
- COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
- (2021) Lindsey E. Roeker et al. LEUKEMIA
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
- (2021) Gino M Dettorre et al. Journal for ImmunoTherapy of Cancer
- Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
- (2021) P. Grivas et al. ANNALS OF ONCOLOGY
- Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study
- (2021) Souad Assaad et al. BRITISH JOURNAL OF CANCER
- Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
- (2021) Laura Mansi et al. EUROPEAN JOURNAL OF CANCER
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
- (2021) Xinxue Liu et al. LANCET
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
- (2021) Sean H Lim et al. Lancet Haematology
- COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
- (2021) Luigi Cavanna et al. Vaccines
- Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France
- (2021) J.Y. Blay et al. ESMO Open
- Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis
- (2021) Son Tran et al. EUROPEAN JOURNAL OF CANCER
- Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article
- (2021) Jérôme Barrière et al. EUROPEAN JOURNAL OF CANCER
- Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study
- (2021) Sheena Mukkada et al. LANCET ONCOLOGY
- Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment
- (2021) A. Grinshpun et al. ESMO Open
- Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
- (2020) M.L. Solodky et al. ANNALS OF ONCOLOGY
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
- (2020) Kunyu Yang et al. LANCET ONCOLOGY
- High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
- (2020) Souad Assaad et al. EUROPEAN JOURNAL OF CANCER
- Risk factors for COVID-19 severity and mortality among solid cancer patients and its impact on anticancer treatment: a nationwide cohort study (GCO-002 CACOVID-19)
- (2020) Astrid Lièvre et al. EUROPEAN JOURNAL OF CANCER
- COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET ONCOLOGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now